Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature

被引：10
作者：
Kantarcioglu, Bulent [1 ,4 ]
Kaygusuz-Atagunduz, Isik [2 ]
Uzay, Ant [3 ]
Toptas, Tayfur [2 ]
Tuglular, Tulin Firatli [2 ]
Bayik, Mahmut [2 ]
机构：
[1] Istanbul Medipol Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey
[2] Marmara Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey
[3] Acibadem Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey
[4] Medipol Mega Hosp Complex, Hematol Clin, TR-34214 Istanbul, Turkey
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2015年 / 102卷 / 03期
关键词：
t(9; 22); Myelodysplastic syndrome; BCR-JAK2; Fusion gene; JAK2; rearrangement; CHRONIC EOSINOPHILIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; JAK2; TRANSLOCATION; PATIENT; GENE; RUXOLITINIB; REARRANGEMENTS; DISORDERS;
D O I：
10.1007/s12185-015-1792-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The human JAK2 gene is mainly targeted by two types of genetic lesions that play roles in the pathogenesis of hematologic malignancies: intragenic mutations and chromosomal translocations. Chromosomal translocations of JAK2 are typically associated with myeloid or lymphoid malignancies with an aggressive course and poor outcome. Here we report a t(9;22)(p24;q11.2) translocation, in a MDS patient and review results associated with BCR-JAK2 fusion reported in the literature.
引用
收藏
页码：383 / 387
页数：5
相关论文
共 19 条
  • [1] Chromosomal translocation t(9;22)(p24;q11) appears to be recurrently associated with myeloid malignancy with aggressive course
    Angelova, Svetlana
    Spassova, Sylva
    Toshkov, Stavri
    Shivarov, Velizar
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (09) : 1809 - 1810
  • [2] Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    Bain, Barbara J.
    Ahmad, Shahzaib
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (06) : 809 - 817
  • [3] Bellesso Marcelo, 2013, Rev. Bras. Hematol. Hemoter., V35, P218, DOI 10.5581/1516-8484.20130044
  • [4] Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements
    Chase, Andrew
    Bryant, Catherine
    Score, Joannah
    Haferlach, Claudia
    Grossmann, Vera
    Schwaab, Juliana
    Hofmann, Wolf-Karsten
    Reiter, Andreas
    Cross, Nicholas C. P.
    [J]. HAEMATOLOGICA, 2013, 98 (03) : 404 - 408
  • [5] A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia
    Cirmena, Gabriella
    Aliano, Stefania
    Fugazza, Giuseppina
    Bruzzone, Roberto
    Garuti, Anna
    Bocciardi, Renata
    Bacigalupo, Andrea
    Ravazzolo, Roberto
    Ballestrero, Alberto
    Sessarego, Mario
    [J]. CANCER GENETICS AND CYTOGENETICS, 2008, 183 (02) : 105 - 108
  • [6] Transforming and Tumorigenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosine-Kinase
    Cuesta-Dominguez, Alvaro
    Ortega, Mara
    Ormazabal, Cristina
    Santos-Roncero, Matilde
    Galan-Diez, Marta
    Luis Steegmann, Juan
    Figuera, Angela
    Arranz, Eva
    Luis Vizmanos, Jose
    Bueren, Juan A.
    Rio, Paula
    Fernandez-Ruiz, Elena
    [J]. PLOS ONE, 2012, 7 (02):
  • [7] BCR-JAK2 fusion as a result of a translocation (9;22)( p24;q11.2) in a patient with CML-like myeloproliferative disease
    Elnaggar, Mohamed M.
    Agersborg, Sally
    Sahoo, Trilochan
    Girgin, Ati
    Ma, Wanlong
    Rakkhit, Ronjay
    Zorrilla, Isabel
    Leal, Alexis
    [J]. MOLECULAR CYTOGENETICS, 2012, 5
  • [8] A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q 11.2) translocation in a patient with a clinically typical chronic myeloid leukemia
    Griesinger, F
    Hennig, H
    Hillmer, F
    Podleschny, M
    Steffens, R
    Pies, A
    Wörmann, B
    Haase, D
    Bohlander, SK
    [J]. GENES CHROMOSOMES & CANCER, 2005, 44 (03) : 329 - 333
  • [9] Two alternatively spliced 5'BCR/3' JAK2 fusion transcripts in a myeloproliferative neoplasm with a three-way t(9;18;22)(p23;p11.3;q11.2) translocation
    Impera, Luciana
    Lonoce, Angelo
    Fanfulla, Domenica Antonella
    Moreilhon, Chimene
    Legros, Laurence
    Raynaud, Sophie
    Storlazzi, Clelia Tiziana
    [J]. CANCER GENETICS, 2011, 204 (09) : 512 - 515
  • [10] Lane Steven W, 2008, Br J Haematol, V142, P503, DOI 10.1111/j.1365-2141.2008.07164.x
12